Liching cao

Company: Sangamo Therapeutics
Job title: Director - Bioanalytical Operations
Seminars:
Clinical Enrolment Assay to Detect Pre-existing Neutralizing Antibodies to AAV6 With Demonstrated Transgene Expression in Gene Therapy Trials 9:00 am
Clinical enrollment cut off determination for pre-screening patients supporting AAV6 gene therapy trials Does assay format matter? NAb or TAb approach for clinical trial eligibility criteria Explore AAV6 seroprevalence evaluationsRead more
day: Day Two